Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT05162872 · UNKNOWN

Trial details

NCT number: NCT05162872
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2021-08-05
Primary completion: 2023-06-30
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.